Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Malignant Solid Neoplasm × dinaciclib × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 1 Advanced Malignant Solid Neoplasm 1

Interventions

veliparib 1 spartalizumab 1 siltuximab 1 dinaciclib 1 Specimen Handling 1 Palliative Care 1 Mindfulness-Based Stress Reduction 1 Mindfulness 1 Methods 1 Magnetic Resonance Spectroscopy 1 Educational Status 1 Early Intervention, Educational 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01434316 2026-03-18

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡